AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE